Literature DB >> 14690151

Cancer survival in Sweden 1960-1998--developments across four decades.

Mats Talbäck1, Magnus Stenbeck, Måns Rosén, Lotti Barlow, Bengt Glimelius.   

Abstract

This paper summarizes a comprehensive study of cancer survival in Sweden from 1960 to 1998. A total of 1021421 persons and 40 different cancer sites were included in the analyses. The main outcome measure is the relative survival rate (RSR) for different sites and follow-up times after diagnosis. The 10-year RSR for all sites combined has increased steadily-from 26.6% among men and 41.8% among women in the 1960s, to 44.6% (men) and 57.6% (women) in the 1990s. The expectation of life for a person diagnosed with cancer today is about 7 years longer than that of one diagnosed during the mid-1960s. About 3 years are gained due to changes in the relative distribution of various cancer types and about 4 years due to improved relative survival. During the 1990s substantial survival improvements were observed not only for uncommon types, such as testicular cancer, Hodgkin's lymphoma and some other haematologic malignancies, but also for cancer of the rectum, kidney and malignant melanoma. Survival for breast and cervical cancer also improved during the 1990s, but not that for pancreatic, liver or lung cancer.

Entities:  

Mesh:

Year:  2003        PMID: 14690151     DOI: 10.1080/02841860310013391

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  19 in total

1.  The status of phosphorylated p38 in esophageal squamous cell carcinoma.

Authors:  Shu-Tao Zheng; Chuan-Shan Zhang; Xu Qin; Yue-Hua Gen; Tao Liu; Ilyar Sheyhidin; Xiao-Mei Lu
Journal:  Mol Biol Rep       Date:  2011-12-14       Impact factor: 2.316

2.  Colorectal cancer patients: what do they die of?

Authors:  Matias Riihimäki; Hauke Thomsen; Kristina Sundquist; Kari Hemminki
Journal:  Frontline Gastroenterol       Date:  2012-04-27

Review 3.  Current role of bone scan with phosphonates in the follow-up of breast cancer.

Authors:  Lorenzo Maffioli; Luigia Florimonte; Luca Pagani; Ivana Butti; Isabel Roca
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-16       Impact factor: 9.236

4.  Relevance of philosophy of life and optimism for psychological distress among individuals in a stage where death is approaching.

Authors:  Jeanette Winterling; Elisabet Wasteson; Birgitta Sidenvall; Erik Sidenvall; Bengt Glimelius; Per-Olow Sjödén; Karin Nordin
Journal:  Support Care Cancer       Date:  2005-08-03       Impact factor: 3.603

5.  Familial risks in nervous system tumours: joint Nordic study.

Authors:  K Hemminki; S Tretli; J H Olsen; L Tryggvadottir; E Pukkala; J Sundquist; C Granström
Journal:  Br J Cancer       Date:  2010-05-25       Impact factor: 7.640

6.  Symptom burden, depression, and spiritual well-being: a comparison of heart failure and advanced cancer patients.

Authors:  David B Bekelman; John S Rumsfeld; Edward P Havranek; Traci E Yamashita; Evelyn Hutt; Sheldon H Gottlieb; Sydney M Dy; Jean S Kutner
Journal:  J Gen Intern Med       Date:  2009-03-14       Impact factor: 5.128

7.  Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.

Authors:  Sabitha Papineni; Sudhakar Chintharlapalli; Maen Abdelrahim; Syng-ook Lee; Robert Burghardt; Ala Abudayyeh; Cheryl Baker; Luis Herrera; Stephen Safe
Journal:  Carcinogenesis       Date:  2009-04-30       Impact factor: 4.944

8.  Survival in non-Hodgkin's lymphoma by histology and family history.

Authors:  Jianguang Ji; Asta Försti; Jan Sundquist; Per Lenner; Kari Hemminki
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-17       Impact factor: 4.553

9.  Quality of life in cancer survivors as observed in a population study of Swedish women.

Authors:  Osten Helgesson; Lauren Lissner; Jörgen Månsson; Calle Bengtsson
Journal:  Scand J Prim Health Care       Date:  2007-12       Impact factor: 2.581

Review 10.  Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Authors:  Paolo Sammartino; Daniele Biacchi; Tommaso Cornali; Maurizio Cardi; Fabio Accarpio; Alessio Impagnatiello; Bianca Maria Sollazzo; Angelo Di Giorgio
Journal:  Indian J Surg Oncol       Date:  2016-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.